通过调节P11-Htr4信号通路,L-NRB可以缓解肌缩性侧面硬化症
Yunfeng Pan1, Xiao Sun1, Yu Tian1
1Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing, China.
L-NRB显示了对肌缩侧面硬化症 (ALS) 的治疗潜力. 这种化合物减轻了运动功能障碍和神经炎症,为ALS患者提供了一个有前途的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- L-NRB是一种新型化合物,由丁甲基和醇衍生.
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病.
研究的目的:
- 研究L-NRB对ALS的治疗作用.
- 阐明L-NRB在治疗ALS的潜在机制.
主要方法:
- 用SOD1-G93A小鼠作为一个既定的ALS模型.
- 采用了行为测试,组织病理学,免疫组织化学,ELISA和西式涂抹.
- 进行了转录组分析,以探索治疗机制.
主要成果:
- L-NRB治疗显著改善了运动功能,并减少了胃半腹肌病理.
- 观察到神经保护,与抑制神经炎症有关.
- 通过调节P11-Htr4信号通路,L-NRB显示出抗亡作用.
结论:
- 在ALS小鼠模型中,L-NRB表现出显著的治疗效果.
- 这些发现表明L-NRB是ALS治疗的潜在新疗法候选者.
更多相关视频
07:14Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
相关概念视频
Neural Regulation
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
